Illicit Drug Use Is a Significant Risk Factor for Loss to Follow Up in Patients with HIV-1 Infection at a Large Urban HIV Clinic in Tokyo

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Nishijima, Takeshi ^a,b   Gatanaga, Hiroyuki ^a,b   Komatsu, Hirokazu ^c   Takano, Misao ^a   Ogane, Miwa ^a   Ikeda, Kazuko ^a   Oka, Shinichi ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ADULT; AGE; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; DRUG ABUSE; FEMALE; FOLLOW UP; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; OBSERVATIONAL STUDY; POPULATION EXPOSURE; RISK ASSESSMENT; RISK FACTOR; URBAN AREA; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LOST TO FOLLOW-UP; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TOKYO;

EID: 84881357091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072310     Document Type: Article

References (38)

1. Egger M, May M, Chêne G, Phillips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360: 119-129. doi:10.1016/S0140-6736(02)09411-4. PubMed: 12126821.
2. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95. doi:10.7326/0003-4819-146-2-200701160-00003. PubMed: 17227932.
3. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, et al. (1998) Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279: 450-454. doi:10.1001/jama.279.6.450. PubMed: 9466638.
4. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, et al. (2004) The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 35: 261-268. doi:10.1097/00126334-200403010-00006. PubMed: 15076240.
5. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. J Acquir Immune Defic Syndr 47: 101-107. doi:10.1097/QAI.0b013e31815b833a. PubMed: 17971708.
6. Bygrave H, Kranzer K, Hilderbrand K, Whittall J, Jouquet G, et al. (2010) Trends in loss to follow-up among migrant workers on antiretroviral therapy in a community cohort in Lesotho. PLOS ONE 5: e13198. doi:10.1371/journal.pone.0013198. PubMed: 20976289.
7. Brennan AT, Maskew M, Sanne I, Fox MP, (2010) The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. J Int Aids Soc 13: 49. doi:10.1186/1758-2652-13-S4-O49. PubMed: 21134297.
8. Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, et al. (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43: 770-776. doi:10.1086/507095. PubMed: 16912954.
9. Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, et al. (2009) Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 48: 248-256. doi:10.1086/595705. PubMed: 19072715.
10. Giordano TP, Gifford AL, White AC Jr., Suarez-Almazor ME, Rabeneck L, et al. (2007) Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 44: 1493-1499. doi:10.1086/516778. PubMed: 17479948.
11. Giordano TP, (2011) Retention in HIV care: what the clinician needs to know. Top Antivir Med 19: 12-16. PubMed: 21852711.
12. Wood E, Montaner JS, Tyndall MW, Schechter MT, O'Shaughnessy MV, et al. (2003) Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis 188: 1164-1170. doi:10.1086/378703. PubMed: 14551887.
13. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, et al. (1998) Barriers to use of free antiretroviral therapy in injection drug users. JAMA 280: 547-549. doi:10.1001/jama.280.6.547. PubMed: 9707146.
14. Malta M, Magnanini MM, Strathdee SA, Bastos FI, (2010) Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 14: 731-747. doi:10.1007/s10461-008-9489-7. PubMed: 19020970.
15. Horstmann E, Brown J, Islam F, Buck J, Agins BD, (2010) Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clin Infect Dis 50: 752-761. PubMed: 20121413.
16. Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, et al. (2009) Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Med 10: 407-416. doi:10.1111/j.1468-1293.2009.00701.x. PubMed: 19490174.
17. Milloy MJ, Marshall BD, Kerr T, Buxton J, Rhodes T, et al. (2012) Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review. AIDS 26: 1049-1063. doi:10.1097/QAD.0b013e32835221cc. PubMed: 22333747.
18. Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, et al. (2003) Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 362: 1267-1274. doi:10.1016/S0140-6736(03)14570-9. PubMed: 14575971.
19. Magnani R, Sabin K, Saidel T, Heckathorn D, (2005) Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19 (Suppl 2):: S67-S72. doi:10.1097/01.aids.0000167353.02289.b9. PubMed: 15930843.
20. Wada K, (2011) The history and current state of drug abuse in Japan. Ann N Y Acad Sci 1216: 62-72. doi:10.1111/j.1749-6632.2010.05914.x. PubMed: 21272011.
21. Tominaga M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, et al. (2009) Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002-2004. Soc Psychiatry Psychiatr Epidemiol 44: 777-783. doi:10.1007/s00127-009-0499-1. PubMed: 19190833.
22. Wada K, Greberman SB, Konuma K, Hirai S, (1999) HIV and HCV infection among drug users in Japan. Addiction 94: 1063-1069. doi:10.1046/j.1360-0443.1999.947106311.x. PubMed: 10707444.
23. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, et al. (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835. doi:10.1097/EDE.0b013e3181577511. PubMed: 18049195.
24. Ndiaye B, Ould-Kaci K, Salleron J, Bataille P, Bonnevie F, et al. (2009) Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France- January 1997 to December 2006. Antivir Ther 14: 567-575. PubMed: 19578242.
25. Rice BD, Delpech VC, Chadborn TR, Elford J, (2011) Loss to follow-up among adults attending human immunodeficiency virus services in England, Wales, and Northern Ireland. Sex Transm Dis 38: 685-690. PubMed: 21844719.
26. Hidaka Y, Ichikawa S, Koyano J, Urao M, Yasuo T, et al. (2006) Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan. BMC Public Health 6: 239. doi:10.1186/1471-2458-6-239. PubMed: 17002800.
27. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO, (2009) Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials 10: 299-305. doi:10.1310/hct1005-299. PubMed: 19906622.
28. Qian HZ, Stinnette SE, Rebeiro PF, Kipp AM, Shepherd BE, et al. (2011) The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abus Treat 41: 14-20. doi:10.1016/j.jsat.2011.01.007. PubMed: 21349679.
29. Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, et al. (2008) Loss to follow-up in an international, multicentre observational study. HIV Med 9: 261-269. doi:10.1111/j.1468-1293.2008.00557.x. PubMed: 18400074.
30. Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, et al. (2006) Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med 7: 140-145. doi:10.1111/j.1468-1293.2006.00357.x. PubMed: 16494627.
31. Latkin CA, Knowlton AR, Sherman S, (2001) Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. J Subst Abus 13: 89-102. doi:10.1016/S0899-3289(01)00070-0. PubMed: 11547627.
32. Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, et al. (2012) Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 23: 37-44. doi:10.1016/j.drugpo.2011.05.014. PubMed: 21689917.
33. Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, et al. (2011) Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil 2: 173-180. PubMed: 23293547.
34. Wada K, (2010) [Epidemiology of drug abuse and dependence]. Nihon Rinsho 68: 1437-1442. PubMed: 20715473.
35. Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, et al. (2010) Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health 87: 480-485. doi:10.1007/s11524-009-9422-z. PubMed: 20101468.
36. Kurtz SP, (2005) Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav 9: 63-72. doi:10.1007/s10461-005-1682-3. PubMed: 15812614.
37. Mansergh G, Shouse RL, Marks G, Guzman R, Rader M, et al. (2006) Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 82: 131-134. doi:10.1136/sti.2005.017129. PubMed: 16581738.
38. Halkitis PN, Green KA, Mourgues P, (2005) Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: findings from Project BUMPS. J Urban Health 82: i18-i25. doi:10.1093/jurban/jti020. PubMed: 15738324.